Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthyroidism × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 36 Neoplasm Metastasis 17 Liver Neoplasms 16 Colorectal Neoplasms 13 Cholangiocarcinoma 11 Lung Neoplasms 9 Pancreatic Neoplasms 8 Colonic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Barrett Esophagus 7 Thyroid Nodule 6 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 4 Pain 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Leiomyoma 3 Kidney Neoplasms 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2

Interventions

Iodine-131 2 Transurethral Resection of Prostate 1 Radiofrequency Ablation 1 Holistic Health 1 Dexmedetomidine 1 Data Collection 1 Calcium Carbonate 1 Calcitriol 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05142904 2025-07-17

RABITO

Rijnstate Hospital

Phase 3 Terminated

Hyperthyroidism, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon ⚡